Supernus Pharmaceuticals (SUPN) shares were up 1.4% in recent Wednesday trading after Cantor Fitzgerald upgraded the stock to overweight from neutral and adjusted its price target to $42 per share from $36.
Trading volume stood at over 292,000 shares compared with a daily average of about 616,000.
Price: 33.91, Change: +0.45, Percent Change: +1.36